Title |
Promoting vascular repair in the retina: can stem/progenitor cells help?
|
---|---|
Published in |
Eye and Brain, May 2016
|
DOI | 10.2147/eb.s94451 |
Pubmed ID | |
Authors |
Thao Le Phuong Trinh, Sergio Li Calzi, Lynn C Shaw, Mervin C Yoder, Maria B Grant |
Abstract |
Since its first epidemic in the 1940s, retinopathy of prematurity (ROP) has been a challenging illness in neonatology. Higher than physiological oxygen levels impede the development of the immature retinal neuropil and vasculature. Current treatment regimens include cryotherapy, laser photocoagulation, and anti-VEGF agents. Unfortunately, none of these approaches can rescue the normal retinal vasculature, and each has significant safety concerns. The limitations of these approaches have led to new efforts to understand the pathological characteristics in each phase of ROP and to find a safer and more effective therapeutic approach. In the era of stem cell biology and with the need for new treatments for ROP, this review discusses the possible future use of unique populations of proangiogenic cells for therapeutic revascularization of the preterm retina. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 50% |
Practitioners (doctors, other healthcare professionals) | 1 | 50% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 23 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 5 | 22% |
Other | 4 | 17% |
Student > Ph. D. Student | 4 | 17% |
Researcher | 2 | 9% |
Lecturer > Senior Lecturer | 1 | 4% |
Other | 3 | 13% |
Unknown | 4 | 17% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 6 | 26% |
Biochemistry, Genetics and Molecular Biology | 4 | 17% |
Agricultural and Biological Sciences | 2 | 9% |
Nursing and Health Professions | 2 | 9% |
Computer Science | 2 | 9% |
Other | 1 | 4% |
Unknown | 6 | 26% |